Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype.
Apolipoprotein E (ApoE) is a potent risk factor for Alzheimer's disease. Since the loss of cholinergic function in Alzheimer's disease is known to occur at an early stage in the disease we have examined this function in normal subjects with an Apoepsilon4 allele to see if the deficit occur...
Κύριοι συγγραφείς: | Allen, S, MacGowan, S, Tyler, S, Wilcock, G, Robertson, A, Holden, P, Smith, S, Dawbarn, D |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
1997
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease.
ανά: MacGowan, S, κ.ά.
Έκδοση: (1998) -
Quantitative morphometric analysis of basal forebrain neurons expressing β-nerve growth factor receptors in normal and Alzheimer's disease brains
ανά: Allen, S, κ.ά.
Έκδοση: (1990) -
Low affinity nerve growth factor receptor binding in normal and Alzheimer's disease basal forebrain.
ανά: Treanor, J, κ.ά.
Έκδοση: (1991) -
Normal beta-NGF content in Alzheimer's disease cerebral cortex and hippocampus.
ανά: Allen, S, κ.ά.
Έκδοση: (1991) -
Alzheimer's disease, herpes virus in brain, apolipoprotein E4 and herpes labialis
ανά: Lin, W, κ.ά.
Έκδοση: (1998)